| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_232361c9031a709144573276863c462b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-46 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-46 |
| filingDate |
1972-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1975-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ca63e8b8b96f5c251680ab6a183333e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f8fb120d6295e4a57e3743bd7812ccf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a8fbc64fdf42f4de0bdebaceb2a560e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e4763056ebb1dab431e018103126f3d |
| publicationDate |
1975-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3887551-A |
| titleOfInvention |
Crystalline forms of cephaloridine |
| abstract |
The invention is concerned with two novel crystalline forms of the antibiotic cephaloridine which are relatively non-hygroscopic compared with previously known forms of cephaloridine and hence possess important advantages in handling and formulation. The novel crystalline forms are characterised in particular by X-ray crystallographic data set out in detail in the following disclosure. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4006138-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7544799-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE43932-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007004746-A1 |
| priorityDate |
1964-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |